CASI Pharmaceuticals (NASDAQ:CASI) Downgraded by BidaskClub to “Buy”

Retrieved on: 2018-03-12 08:11:15

Tags for this article:

Click the tags to see associated articles and topics

CASI Pharmaceuticals (NASDAQ:CASI) Downgraded by BidaskClub to “Buy”. View article details on hiswai:

Excerpt

<div><b>Millennium Management</b> LLC purchased a new position in shares of CASI Pharmaceuticals during the fourth quarter worth $137,000. Perceptive Advisors LLC acquired a new stake in CASI Pharmaceuticals during the fourth quarter valued at $272,000. Renaissance Technologies LLC grew its position ...</div>

Article found on:

View Original Article